切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2015, Vol. 09 ›› Issue (03) : 211 -215. doi: 10.3877/cma.j.issn.1674-0793.2015.03.008

所属专题: 文献

论著

肝移植术后两种极端糖尿病性昏迷的临床分析
周健1, 鞠卫强1, 袁小鹏1, 陈传宝1, 焦兴元1, 朱晓峰1, 王东平1, 何晓顺1,()   
  1. 1. 510080 广州,中山大学附属第一医院器官移植中心
  • 收稿日期:2014-11-04 出版日期:2015-06-01
  • 通信作者: 何晓顺
  • 基金资助:
    国家自然科学基金资助项目(81170448); 高等学校博士学科点专项科研基金新教师类资助课题(20130171120076); 国家科技支撑计划资助项目(2008BAI60B02); 教育部博士点-博导类资助项目(20100171110063)

Clinical analysis of two extreme diabetic comas after liver transplantation

Jian Zhou1, Weiqiang Ju1, Xiaopeng Yuan1, Chuanbao Chen1, Xingyuan Jiao1, Xiaofeng Zhu1, Dongping Wang1, Xiaoshun He1,()   

  1. 1. Organ Transplantation Center, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
  • Received:2014-11-04 Published:2015-06-01
  • Corresponding author: Xiaoshun He
  • About author:
    Corresponding author: He Xiaoshun, Email:
引用本文:

周健, 鞠卫强, 袁小鹏, 陈传宝, 焦兴元, 朱晓峰, 王东平, 何晓顺. 肝移植术后两种极端糖尿病性昏迷的临床分析[J/OL]. 中华普通外科学文献(电子版), 2015, 09(03): 211-215.

Jian Zhou, Weiqiang Ju, Xiaopeng Yuan, Chuanbao Chen, Xingyuan Jiao, Xiaofeng Zhu, Dongping Wang, Xiaoshun He. Clinical analysis of two extreme diabetic comas after liver transplantation[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2015, 09(03): 211-215.

目的

探讨肝移植术后基于移植后糖尿病(PTDM)的高渗性非酮症高血糖昏迷(HNKHC)和酮症酸中毒(DKA)的诊治。

方法

回顾性分析本院2005年1月至2013年12月完成的805例肝移植患者资料,总结2例HNKHC和DKA患者的诊治经过。2例术前均无糖尿病史,肝移植术后均服用他克莫司和雷帕鸣抗排斥,1例女性患者曾给予甲强龙冲击治疗急性排斥反应,另1例男性患者入院后将他克莫司改为环孢素。

结果

例1诊断为HNKHC,例2诊断为DKA。2例经给予快速大量补液、小剂量胰岛素持续静脉滴注、纠正电解质及酸碱平衡紊乱等综合治疗,患者临床症状和体征消失,最终病愈出院。随访半年均未再发HNKHC、DKA和PTDM。

结论

肝移植术后HNKHC和DKA的发病率极低,但病情凶险,预后取决于准确的诊断和及时有效的综合治疗措施。无糖尿病史的肝移植患者术后昏迷应警惕HNKHC和DKA的发生。

Objective

To summarize the diagnosis and treatment of hyperosmolar non-ketotic hyperglycemic coma (HNKHC) and diabetic ketoacidosis (DKA) based on post-transplant diabetes mellitus (PTDM) after liver transplantation.

Methods

The data of 805 patients with liver transplantation in our hospital from January 2005 to December 2013 was reviewed retrospectively. Only 2 cases with HNKHC and DKA were found out. Both cases had no history of diabetes, and used tacrolimus and sirolimus for immunosuppression. After admission, the female had been given methylprednisolone impulse therapy for acute rejection, and tacrolimus was transformed into sirolimus for the male patient.

Results

The female patient was diagnosed as HNKHC, and the male patient suffered from DKA. After comprehensive treatment, such as rapid rehydration, small doses of insulin continuously intravenous dripping, correcting electrolyte and acid-base balance disorders, the symptoms and signs disappeared, and the patients is eventually discharged from the hospital. There was no recurrence on HNKHC, DKA and PTDM after 6 months follow-up.

Conclusions

The morbidity of post-liver transplantation HNKHC and DKA is extremely low, but they are extremely dangerous. The prognosis depends on accurate diagnosis and effective comprehensive treatment in a timely manner.

表1 2例肝移植患者HNKHC和DKA实验室检查结果
图1 例1肝脏穿刺活组织病理学检查(HE染色,×10倍)
[1]
John PR, Thuluvath PJ. Outcomes of patients with new-onset diabets mellitus after liver transplantation compared with those without diabetes mellitus[J]. Liver Transpl, 2002, 8(8): 708-713.
[2]
Moon JI, Barbeito R, Faradji RN, et al. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up[J]. Transplantation, 2006, 82(12): 1625-1628.
[3]
Saab S, Shpaner A, Zhao Y, et al. Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation[J]. Am J Transplant, 2006, 6(8): 1890-1895.
[4]
Tsochatzis E, Koskinas J, Manesis EK, et al. Liver transplantation in Greek patients: epidemiological data, morbidity, and mortality of 71 patients from a single center with 6 years of mean follow-up[J]. Transplant Proc, 2007, 39(5): 1505-1507.
[5]
American Diabetes Association. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care, 2004, 27(Suppl 1): S5-S10.
[6]
Saliba F, Lakehal M, Pageaux GP, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study[J]. Liver Transpl, 2007, 13(1): 136-144.
[7]
Ahn HY, Cho YM, Yi NJ, et al. Predictive factors associated with the reversibility of post-transplantation diabetes mellitus following liver transplantation[J]. J Korean Med Sci, 2009, 24(4): 567-570.
[8]
Mora PF. Post-transplantation diabetes mellitus[J]. Am J Med Sci,2005, 329(2): 86-94.
[9]
Paty BW, Harmon JS, Marsh CL, et al. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets[J]. Transplantation, 2002, 73(3): 353-357.
[10]
Redmon JB, Olson LK, Armstrong MB, et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells[J]. J Clin Invest, 1996, 98(12): 2786-2793.
[11]
Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age[J]. Transplantation, 1997, 64(7): 979-983.
[12]
Richards J, Gunson B, Johnson J, et al. Weight gain and obesity after liver transplantation[J]. Transpl Int, 2005, 18(4): 461-466.
[13]
Valabhji J, Watson M, Cox J, et al. Type 2 diabetes presenting as diabetic ketoacidosis in adolescence[J]. Diabet Med, 2003, 20(5): 416-467.
[14]
Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in diabetes[J]. Diabetes Care, 2004, 27(Suppl 1): S94-S102.
[15]
Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes[J]. Diabetes Care, 2009, 32(7): 1335-1343.
[16]
Ali Z, Levine B, Ripple M, et al. Diabetic ketoacidosis: a silent death[J]. Am J Forensic Med Pathol, 2012, 33(3): 189-193.
[17]
Tokuda Y, Omata F, Tsugawa Y, et al. Vital sign triage to rule out diabetic ketoacidosis and non-ketotic hyperomolar syndrome in hyperglycemic patients[J]. Diabetes Res Clin Pract, 2010, 87(3): 366-371.
[18]
Saliba F, Lakehal M, Pageaux GP, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study[J]. Liver Transpl, 2007, 13(1): 136-144.
[19]
Mirabella S, Brunati A, Ricchiuti A, et al. New-onset diabetes after liver transplantation[J]. Transplant Proc, 2005, 37(6): 2636-2637.
[20]
Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States[J]. Am J Transplant, 2003, 3(2): 178-185.
[21]
Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes[J]. Nat Rev Mol Cell Biol, 2008, 9(5): 367-377.
[22]
Panz VR, Bonegio R, Raal FJ, et al. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation[J]. Transplantation, 2002, 73(4): 587-590.
[23]
Knobler H, Stagnaro-Green A, Wallenstein S, et al. Higher incidence of diabetes in liver transplant recipients with hepatitis C[J]. J Clin Gastroenterol, 1998, 26(1): 30-33.
[24]
Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines[J]. Transplantation, 2003, 75(Suppl): SS3-SS24.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[8] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[9] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[10] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[13] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[14] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?